AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Fertility

    Triptorelin (GnRH) (2mg)

    Intramuscular or SubcutaneousOne-time (single shot) or weekly micro-dose2mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    🇺🇸 FDA (Trelstar®)
    🇪🇺 EMA (Decapeptyl®)

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    FDA & EMA approved — for specific indications
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Free Access

    How It Works

    Triptorelin (D-Trp6-GnRH) is a synthetic decapeptide GnRH analog with a D-tryptophan substitution at position 6, which dramatically increases stability and potency (100× more potent than natural GnRH). In **micro-doses** (50–100 mcg), it acts as an acute GnRH agonist, causing a transient release of LH and FSH from the anterior pituitary. This 'wakes up' the HPG axis that was suppressed by exogenous substances. LH stimulates the Leydig cells of the testes to produce testosterone, while FSH supports spermatogenesis. **At high doses** (mg), continuous occupation of GnRH receptors causes downregulation via receptor internalization, leading to complete LH/FSH suppression — chemical castration. This is why dosing accuracy is of vital importance.

    Quick Start

    • Reconstitution: Add 2.0 mL bacteriostatic water → 1 mg/mL (1000 mcg/mL).
    • PCT Dose: Single injection of 100 mcg (NOT mg) — 'one-shot PCT'.
    • ⚠️ CRITICAL: 100 mcg ≠ 100 mg. Wrong unit = chemical castration. TRIPLE-check.
    Detailed Protocol Data

    PCT Micro-Dose (2 mL = 1 mg/mL)

    Educational only
    Vial Size— affects syringe units
    BAC Water2 mL
    Concentration1.00 mg/mL

    Route: Intramuscular or Subcutaneous | Frequency: One-time (single shot) or weekly micro-dose

    WeekDoseUnits (per injection)
    One-Shot PCT
    100 mcg (0.1 mg)
    10 Units (0.10 mL)
    Low-Dose PCT (alt.)
    50 mcg (0.05 mg)
    5 Units (0.05 mL)

    One-Shot PCT: A single injection of 100 mcg after complete clearance of exogenous substances. Low-Dose: 50 mcg once, often combined with a SERM (Tamoxifen/Clomid) for 14–28 days. ⚠️ DO NOT use mg doses.

    Related compounds

    Reconstitution Steps

    1. Withdraw 2.0 mL of bacteriostatic water.
    2. Inject slowly against the wall · do not spray directly onto the powder.
    3. Gently swirl until fully dissolved — do not shake.
    4. Note the concentration (1 mg/mL = 1000 mcg/mL) and date.
    5. Refrigerate at 2–8 °C · use within 28 days.

    Protocol Overview

    • Goal: Restart the HPG axis after an anabolic or exogenous testosterone cycle.
    • Schedule: A single 100 mcg injection ('one-shot PCT') or a single 50 mcg injection + SERM.
    • CRITICAL: Doses in mg (3.75+ mg) are used in prostate cancer therapy and cause chemical castration.
    • Timing: Inject ONLY after exogenous compounds have fully cleared.

    Dosing Protocol

    • One-Shot PCT: 100 mcg intramuscularly or subcutaneously — single injection.
    • Low-Dose PCT: 50 mcg single injection + Tamoxifen 20mg/day or Clomid 25–50mg/day × 14–28 days.
    • Timing: After full clearance of exogenous substances — depends on half-life.
    • ⚠️ DO NOT repeat within 4 weeks — triptorelin has a potent effect on the HPG axis.
    • Break between cycles: After injection, wait 4–6 weeks before evaluating your hormone panel. Do not use again without laboratory assessment.

    Washout & Cycle Restart

    When can I restart?

    After injection, wait 4–6 weeks before evaluating your hormone panel. Do not use again without laboratory assessment.

    Minimum wait period: 4 weeks

    Storage Instructions

    • Lyophilized: −20 °C in dark, dry conditions.
    • Reconstituted: Refrigerate 2–8 °C · use within 28 days.
    • Avoid freeze-thaw cycles.

    Important Notes

    • ⚠️ CRITICAL DOSING WARNING: 100 mcg (micrograms), NOT 100 mg. Doses in mg cause chemical castration.
    • Triptorelin is ~100× more potent than natural GnRH.
    • Do not use if exogenous substances have not fully cleared.
    • Single use — does not require cycles or repetitions in most cases.
    • Check hormone panel (LH, FSH, testosterone) 4–6 weeks after.
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Rapid HPG axis restart in a 'one-shot' protocol.
    • More potent and targeted than Gonadorelin due to the D-Trp6 modification.
    • Simplicity: a single injection instead of weekly PCT regimens.

    Potential Side Effects:

    • Overdose = chemical castration: The most significant concern. Doses in mg completely suppress testosterone.
    • Transient 'flare': a temporary increase in LH/testosterone before potential stabilization.
    • Possible headache, hot flashes, or mood changes after injection.
    • Rare injection site reactions.

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    🧬 Endocrine
    ⬛ FDA Black Box Warning

    Complete gonadotropin suppression (chemical castration)

    Triptorelin is a GnRH agonist that after initial flare-up completely suppresses LH/FSH, testosterone, and estradiol. Causes reversible chemical castration. Requires medical supervision.

    📄 FDA Label — Trelstar®
    ❤️ Cardiovascular
    🔴 High Risk

    Cardiovascular risk due to hypogonadism

    Androgen deprivation therapy (ADT) with GnRH agonists is associated with increased risk of MI, stroke, and QT prolongation.

    📄 JAMA, 2011

    References

    1. Triptorelin: Pharmacological Properties and Clinical Use in Prostate Cancer — Triptorelin: a review of its pharmacological properties and clinical use in prostate cancer
      View Source
    2. Triptorelin PCT Protocol: Dosage and Usage Guide — Sarms.io — Triptorelin PCT protocol: dosage and usage guide
      View Source
    3. GnRH Agonist and Antagonist Mechanisms in Reproductive Medicine (PMC) — GnRH agonist and antagonist mechanisms in reproductive medicine
      View Source
    4. Recovery of HPT Axis Function After Chronic Steroid Use — Recovery of hypothalamic-pituitary-testicular axis function after chronic steroid use
      View Source
    5. Triptorelin Pamoate (Decapeptyl): European Assessment Report — EMA — Triptorelin pamoate (Decapeptyl): European assessment report
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Approved
    FDA Status
    2
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    🇺🇸
    FDA
    Approved

    Trelstar® · Advanced prostate cancer (2000)

    🇪🇺
    EMA
    Approved

    Decapeptyl® · Prostate cancer, endometriosis (1986)

    FDA/EMA-approved GnRH agonist for prostate cancer, precocious puberty and endometriosis.

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Summary:
    2 Approvals
    0 PubMed
    0 Clinical Studies

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu